Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis
Transcatheter Aortic Valve Replacement in Severe Low Flow, Low Gradient Aortic Stenosis: the Multicenter LOW-TAVR Registry
University of Salerno
1,350 participants
Mar 1, 2024
OBSERVATIONAL
Conditions
Summary
LOW-TAVR is a real-world, retrospective and prospective, multicenter Italian registry aimed at evaluating the characteristics and clinical outcomes of patients with severe low flow, low gradient aortic stenosis undergoing transcatheter aortic valve replacement (TAVR) and, in particular: * risk factors * gender differences * comorbidities * pharmacological treatment * TAVR procedural characteristics * periprocedural and in-hospital complications * clinical outcome at 30-day, 1-year, 2-year and 5-year follow-up
Eligibility
Inclusion Criteria3
- LFLG-AS diagnosis according to current European Society of Cardiology guidelines
- Age 18 years or older
- Written informed consent
Exclusion Criteria2
- LFLG-AS pseudo-severe or non-confirmed severe aortic stenosis
- LFLG-AS referred for medical treatment or undergoing surgery
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Transcatheter aortic valve replacement with implantation of new-generation balloon-expandable or self-expandable bioprostheses
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06589063